In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.

A number of research firms have changed their ratings and price targets for Couchbase (NASDAQ: BASE): 2/27/2025 – Couchbase had its price target lowered by analysts at The Goldman Sachs Group, Inc.

While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...

Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, today announced that First ...

Abstract Genome-wide identification of binding profiles for DNA-binding proteins from the limited number of intracellular pathogens in infection ...

Arc Institute, a research organization that operates in collaboration with UC Berkeley, has released an artificial ...

A critically endangered new species of killifish sampled from an ancient forest in Kenya in 2017 and 2018 has been described ...

The global electrophoresis market is set to witness substantial growth, with its valuation projected to rise from USD 2,268.8 million in 2023 to USD 3,523.50 million by 2033. This expansion reflects a ...

Audi is reportedly preparing a plug-in hybrid R8 based on the Lamborghini Temerario. With an electrified twin-turbo V8, it ...

The basic repeating structural (and functional) unit of chromatin is the nucleosome, which contains eight histone proteins and about 146 base pairs of DNA (Van Holde, 1988; Wolffe, 1999).